SARomics Biostructures – Structural Biology and Drug Discovery Contract Services
SARomics Biostructures is a leading structural biology and drug discovery CRO based in Medicon Village, Lund, Sweden. It specializes in providing advanced structural biology and integrated drug discovery outsourcing services.
Structural Biology & Drug Discovery CRO
The company was founded in 2006 by scientists with a mission to accelerate clients’ drug discovery projects by offering premium structural biology services and drug discovery CRO services. Starting with just one employee and a small crystallization room at the MAX II synchrotron, we developed a fully equipped platform with advanced technology to support structural biology and drug discovery. The platform includes protein cloning, expression, purification, biophysical characterization, crystallization, and structure determination using X-ray crystallography and NMR spectroscopy. Our fragment screening capabilities include proprietary fragment libraries, weak-affinity chromatography (WAC) technology, and NMR– and crystallographic fragment screening.
Located at Medicon Village in Lund, near the 4th-generation MAX IV synchrotron, we provide priority access to the BioMAX and MicroMax beamlines, which are equipped for crystallographic fragment screening and serial crystallography experiments. Our FastLane library, which includes over 600 off-the-shelf drug target proteins for crystallization with our clients’ ligands and a turnaround time of just a few weeks, further accelerates clients’ drug discovery projects.
Over the past twenty years, we have worked with the majority of the top ten pharmaceutical companies, many of the world’s most innovative biotech firms, and academic groups across a broad range of drug-target classes. Many of the projects are documented in the extensive list of published papers, including 8 in Nature journals and more than 10 in other high-impact journals. Hundreds of disclosable crystal structures have been deposited in the Protein Data Bank (PDB), with many additional structures provided directly to clients.
What are our customers saying about our company services?
A recent customer survey (October 2023) showed that more than 90% of our customers are happy or very happy with our company’s structural biology and drug discovery services and are ready to recommend us to others. More than 50% said they contacted us after a colleague’s recommendation. Among the comments we received:
Excellent team, awesome science, and always a pleasure to work with! The team is very communicative and always available for 1:1 discussions.
Highly flexible in terms of project structures, pricing, and delivery. I always highly recommend SARomics, and they are my preferred CRO of all the partners we regularly use.
“Fantastic collaboration, very professional and easy to discuss with, always proactive and flexible. Thank you!”
“Very satisfied with all phases of the project from initiation to delivery. Very professional company”.
“SARomics has been a good partner. We appreciate working with you”.
See also our blog post on the advantages of outsourcing early drug discovery services to a CRO.
Additional information about our experimental platform is available in our technology platform overview.
The presentation of our structural biology and drug discovery platform took place during a virtual meeting jointly organized by SciLifeLab Sweden and the MAX IV BioMax beamline. The webinar focused on “Drug discovery & development opportunities for industry at SciLifeLab and MAX IV.” The total duration is about 14 minutes.